BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 31889124)

  • 1. A novel phytocannabinoid isolated from Cannabis sativa L. with an in vivo cannabimimetic activity higher than Δ
    Citti C; Linciano P; Russo F; Luongo L; Iannotta M; Maione S; Laganà A; Capriotti AL; Forni F; Vandelli MA; Gigli G; Cannazza G
    Sci Rep; 2019 Dec; 9(1):20335. PubMed ID: 31889124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isolation of a High-Affinity Cannabinoid for the Human CB1 Receptor from a Medicinal
    Linciano P; Citti C; Luongo L; Belardo C; Maione S; Vandelli MA; Forni F; Gigli G; Laganà A; Montone CM; Cannazza G
    J Nat Prod; 2020 Jan; 83(1):88-98. PubMed ID: 31891265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of a new cannabidiol n-hexyl homolog in a medicinal cannabis variety with an antinociceptive activity in mice: cannabidihexol.
    Linciano P; Citti C; Russo F; Tolomeo F; Laganà A; Capriotti AL; Luongo L; Iannotta M; Belardo C; Maione S; Forni F; Vandelli MA; Gigli G; Cannazza G
    Sci Rep; 2020 Dec; 10(1):22019. PubMed ID: 33328530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isolation and Pharmacological Evaluation of Minor Cannabinoids from High-Potency Cannabis sativa.
    Radwan MM; ElSohly MA; El-Alfy AT; Ahmed SA; Slade D; Husni AS; Manly SP; Wilson L; Seale S; Cutler SJ; Ross SA
    J Nat Prod; 2015 Jun; 78(6):1271-6. PubMed ID: 26000707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phytocannabinoid Pharmacology: Medicinal Properties of
    Sampson PB
    J Nat Prod; 2021 Jan; 84(1):142-160. PubMed ID: 33356248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. (-)-
    Bueno J; Greenbaum EA
    J Nat Prod; 2021 Feb; 84(2):531-536. PubMed ID: 33565878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cannabinoid receptor 1 binding activity and quantitative analysis of Cannabis sativa L. smoke and vapor.
    Fischedick J; Van Der Kooy F; Verpoorte R
    Chem Pharm Bull (Tokyo); 2010 Feb; 58(2):201-7. PubMed ID: 20118579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different receptor mechanisms underlying phytocannabinoid- versus synthetic cannabinoid-induced tetrad effects: Opposite roles of CB
    Wang XF; Galaj E; Bi GH; Zhang C; He Y; Zhan J; Bauman MH; Gardner EL; Xi ZX
    Br J Pharmacol; 2020 Apr; 177(8):1865-1880. PubMed ID: 31877572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological evaluation of the natural constituent of Cannabis sativa, cannabichromene and its modulation by Δ(9)-tetrahydrocannabinol.
    DeLong GT; Wolf CE; Poklis A; Lichtman AH
    Drug Alcohol Depend; 2010 Nov; 112(1-2):126-33. PubMed ID: 20619971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular Pharmacology of Phytocannabinoids.
    Turner SE; Williams CM; Iversen L; Whalley BJ
    Prog Chem Org Nat Prod; 2017; 103():61-101. PubMed ID: 28120231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phytochemical Characterization and TRPA1/TRPM8 Modulation Profile of the Cannabigerol-Rich
    Gargiulo E; Moriello AS; Benetti E; Pagni L; Arnoldi L; De Petrocellis L; Chianese G; Vitale RM; Taglialatela-Scafati O
    J Nat Prod; 2024 Apr; 87(4):722-732. PubMed ID: 38408345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular Targets of the Phytocannabinoids: A Complex Picture.
    Morales P; Hurst DP; Reggio PH
    Prog Chem Org Nat Prod; 2017; 103():103-131. PubMed ID: 28120232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The novel heptyl phorolic acid cannabinoids content in different Cannabis sativa L. accessions.
    Linciano P; Russo F; Citti C; Tolomeo F; Paris R; Fulvio F; Pecchioni N; Vandelli MA; Laganà A; Capriotti AL; Biagini G; Carbone L; Gigli G; Cannazza G
    Talanta; 2021 Dec; 235():122704. PubMed ID: 34517579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phytocannabinoids: a unified critical inventory.
    Hanuš LO; Meyer SM; Muñoz E; Taglialatela-Scafati O; Appendino G
    Nat Prod Rep; 2016 Nov; 33(12):1357-1392. PubMed ID: 27722705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro and in vivo pharmacological activity of minor cannabinoids isolated from Cannabis sativa.
    Zagzoog A; Mohamed KA; Kim HJJ; Kim ED; Frank CS; Black T; Jadhav PD; Holbrook LA; Laprairie RB
    Sci Rep; 2020 Nov; 10(1):20405. PubMed ID: 33230154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biosynthetic origins of unusual cannabimimetic phytocannabinoids in Cannabis sativa L: A review.
    Welling MT; Deseo MA; Bacic A; Doblin MS
    Phytochemistry; 2022 Sep; 201():113282. PubMed ID: 35718133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Valorization of CBD-hemp through distillation to provide essential oil and improved cannabinoids profile.
    Zheljazkov VD; Maggi F
    Sci Rep; 2021 Oct; 11(1):19890. PubMed ID: 34615971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of dependence potential and abuse liability of Δ
    Vanegas SO; Reck AM; Rodriguez CE; Marusich JA; Yassin O; Sotzing G; Wiley JL; Kinsey SG
    Drug Alcohol Depend; 2022 Nov; 240():109640. PubMed ID: 36179506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cis-Δ
    Tolomeo F; Russo F; Kaczorova D; Vandelli MA; Biagini G; Laganà A; Capriotti AL; Paris R; Fulvio F; Carbone L; Perrone E; Gigli G; Cannazza G; Citti C
    J Pharm Biomed Anal; 2022 Sep; 219():114958. PubMed ID: 35930832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular Mechanism and Cannabinoid Pharmacology.
    Schurman LD; Lu D; Kendall DA; Howlett AC; Lichtman AH
    Handb Exp Pharmacol; 2020; 258():323-353. PubMed ID: 32236882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.